Updated on Jun 30, 2022 | Insights
Recent advances in the hunt for a Zika vaccine bring a glimmer of hope in the battle against a disease threatening to spread across the globe, but also recognition of just how difficult it is to defeat this malignant virus.
Read the article
Updated on Jun 30, 2022 | Insights
It’s time to unleash the power of free-market economics to resolve a continuing outrage in the generic drug industry. Price gouging by rogue financial operators posing as pharma companies, most notably Valeant Pharmaceuticals and Turing Pharmaceuticals AG, has been possible because they have exploited distortions in supply and demand. The free market can correct those distortions.
